Alamar Biosciences, Inc. SEC filings ALMR

Alamar Biosciences, Inc. has 63 filings in SEC EDGAR's recent list, going back to Jan 9, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations, officer or director change). The company's fiscal year ends on December 31.

Alamar Biosciences, Inc. SEC filings
Form Description Filed Period
S-8 Employee stock plan registration Apr 20, 2026 —
POS AM Filing Apr 20, 2026 —
424B4 Prospectus Apr 17, 2026 —
S-1MEF Filing Apr 16, 2026 —
S-1/A Amended registration statement Apr 16, 2026 —
S-1/A Amended registration statement Apr 13, 2026 —
S-1 Registration statement Mar 27, 2026 —

Showing 7 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Laboratory Analytical Instruments (SIC 3826)
Listed as
ALMR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Fremont, CA
SEC filer status
Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK
2104204

Other Laboratory Analytical Instruments companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.